A

AC Immune SA
D

ACIU

2.65000
USD
-0.01
(-0.45%)
مغلق
حجم التداول
1,531
الربح لكل سهم
0
العائد الربحي
-
P/E
-6
حجم السوق
262,199,300
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    C
    CRBP
    -0.09000
    (-1.09%)
    8.20000 USD
    D
    DRRX
    0.02690
    (3.48%)
    0.80000 USD
    J
    JAGX
    0.00810
    (0.94%)
    0.87420 USD
    S
    SNDX
    0.380
    (2.38%)
    16.370 USD
    T
    TGTX
    -0.040
    (-0.13%)
    30.900 USD
    T
    TNXP
    -0.53000
    (-5.48%)
    9.15000 USD
    المزيد
الأخبار
المقالات

العنوان: AC Immune SA

القطاع: Healthcare
الصناعة: Biotechnology
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.